Amanda Galdi
Family · North Liberty, IANPI 1649892340
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 54.9% of the total. Reporting peaked in 2023 at $6,225 and has fallen 79.1% since, to $1,304 in 2025. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $87.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$8K
- Boston Scientific$2K
- AstraZeneca$745
- Johnson & Johnson$622
- Merck$562
- Shockwave Medical, Inc$505
- plus $1K from 15 others
What the payments were for
- Travel & lodging$6,55148%
- Food & beverage$6,95251%
- Education$2132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 44 | $7,529 |
| Boston Scientific | 20 | $2,360 |
| AstraZeneca | 15 | $745 |
| Johnson & Johnson | 14 | $622 |
| Merck | 15 | $562 |
| Shockwave Medical, Inc | 3 | $505 |
| Medtronic | 3 | $300 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $215 |
| Novartis | 7 | $179 |
| Galderma Laboratories, L.p. | 1 | $124 |
| Bayer | 6 | $108 |
| Amgen | 4 | $95 |
| Irhythm Technologies, Inc. | 3 | $87 |
| Revance Therapeutics, Inc. | 4 | $72 |
| Amarin Pharma, Inc. | 3 | $71 |
| Boehringer Ingelheim | 1 | $31 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Novo Nordisk | 1 | $26 |
| Philips North America LLC | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclose Maven Catheter$5,483
- Varithena Administration Pack$1,360
- Watchman$581
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$505
- VERQUVO$500
- XARELTO$425
- FARXIGA$249
- VenaSeal$129
- LOKELMA$122
- WAINUA$121
- LifeVest$107
How this compares
$13,715 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Furosemide | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other family in North Liberty
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Jaclyn MeisSioux City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.